AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

FTLF · NASDAQ · Packaged Foods

FitLife Brands

Markets nutritional supplements and wellness products through an acquired brand portfolio.

$10.10

After-hours close+0.33 (+3.38%)

At close$9.77(−3.27%)

Something off on this page? Send us feedback.

Profile

FitLife Brands, Inc.FTLFConsumer Staples

Markets proprietary nutritional supplements and wellness products through NDS, iSatori, MRC, MusclePharm and Irwin-related product groups. Its portfolio grew through a series of acquisitions, and its common stock trades on the Nasdaq Capital Market.

Develops and markets proprietary nutritional supplements and wellness products for health-conscious consumers.

NDS, iSatori, MRC, MusclePharm and Irwin-related products form its current brand groupings in the reporting business. Purchases of Nutrology assets, Mimi’s Rock, MusclePharm assets and Irwin-related assets expanded the portfolio.

Based in Omaha, the company moved its common stock from OTC trading to the Nasdaq Capital Market. The Irwin asset purchase was funded with a term loan, a credit line and cash. The current product groups show acquired brands in the reporting business but do not establish long-run integration outcomes.

Company facts

CEODayton Judd

ListedSep 18, 2023

ExchangeNASDAQ

HeadquartersOmaha, NE

CountryUnited States

Employees39

CIK0001374328

ISINUS33817P4054

Key statistics

Market cap$91.9M

EPS (ttm)$0.6200

P/E (ttm)15.79

ROE14.0%

P/B1.94

P/S0.9075

Dividend yield—

Beta0.28vs XLP 0.72

Year to date −38.0% · Average volume (30d) 12.4K

Analysts

Price target, next 12 months$30.50+211.5%Median of 2 analysts · vs the Aug 28 close

ConsensusBuy2 of 2 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $9.79

High$40.00+308.6%

Median$30.50+211.5%

Low$21.00+114.5%

12 months agoNowIn 12 months

Latest analyst notes

No analyst notes in the last 24 months.

Earnings

EPS

Estimate$0.25

ReportedDue Nov 12, 2026

Revenue

Estimate$26.8M

ReportedDue Nov 12, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 13, 2026Q2 FY26	$0.20	$0.20	+2.6%	$26.0M	$26.5M	+2.1%	+9.06%
May 14, 2026Q1 FY26	$0.14	$0.17	+21.4%	$24.9M	$25.3M	+1.8%	+2.54%
Mar 31, 2026Q4 FY25	$0.25	$0.25	0.0%	$27.0M	$25.9M	−4.0%	−14.79%
Nov 13, 2025Q3 FY25	$0.25	$0.19	−24.0%	$23.9M	$23.5M	−1.6%	−2.01%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$15.9M	$16.1M	$23.5M	$25.9M	$25.3M	$26.5M
Gross profit	$6.9M	$6.9M	$8.7M	$8.9M	$9.3M	$9.8M
Operating income	$3.0M	$2.5M	$2.3M	$2.5M	$3.1M	$3.4M
Net income	$2.0M	$1.7M	$921.0K	$1.6M	$1.7M	$2.0M
Diluted EPS	$0.20	$0.18	$0.09	$0.16	$0.17	$0.20
Gross margin	43.1%	42.8%	37.2%	34.5%	36.6%	37.0%
Operating margin	18.6%	15.6%	9.9%	9.6%	12.1%	12.6%

Fiscal years (4-quarter sums)FY21 $27.6M · FY22 $29.1M · FY23 $52.7M · FY24 $64.5M · FY25 $81.5M

Revenue by geography · Q2 FY26

United States$25.1M · 95%

Non-US$1.5M · 5%

Balance sheet, Jun 30, 2026Cash & short-term investments $1.1M · Total debt $38.4M · Total assets $102.6M · Shareholders' equity $47.4M

Dividends

No dividends on record.

Ownership

Institutions 8.85%831.2K sharesInsiders 13.71%1.29M sharesOther 77.44%7.27M shares

Shares outstanding 9.39M · Float 7.96M · 84.8% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Judd Dayton · director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER	1.03M	10.98%	Form 4	Apr 2, 2025
Askeladden Capital Management LLC	498.0K	5.40%	13G	Feb 14, 2025
Grant Robert Dawson · director	158.0K	1.68%	Form 4	Apr 14, 2026
BlackRock, Inc.	157.4K	1.68%	13F	May 13, 2026
Vanguard Capital Management LLC	154.6K	1.65%	13F	May 15, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Aug 19, 2026	Shannon K. Pappas	director	+1,000	$10.25
Jan 15, 2026	Seth Yakatan	director	+164	$15.36
Apr 10, 2026	Grant Robert Dawson	director	+3,000	$9.98
Apr 10, 2026	Matthew Lingenbrink	director	+3,000	$9.76